Health Catalyst (HCAT) last issued guidance on March 12, 2026 for Q1 2026. The company guided revenue in the range of $68.00M - $70.00M for the period.

Compared to prior guidance, Health Catalyst lowered its revenue forecast from a prior range of $73.50M - $73.50M.

Health Catalyst has issued 34 guidance updates between May 10, 2022 and March 12, 2026. During this period, the company raised its outlook 4 times and lowered it 17 times, providing investors with insight into management's evolving expectations.